Targeted therapy: Larotrectinib effective against TRK-fusion-positive cancers

Targeted therapy: Larotrectinib effective against TRK-fusion-positive cancersTargeted therapy: Larotrectinib effective against TRK-fusion-positive cancers, Published online: 13 March 2018; doi:10.1038/nrclinonc.2018.40Targeted therapy: Larotrectinib effective against TRK-fusion-positive cancers

https://www.nature.com/articles/nrclinonc.2018.40

Source: Nature Clinical Practice Oncology - March 13, 2018 Category: Cancer & Oncology Authors: Peter Sidaway Source Type: research

More News: Cancer | Cancer & Oncology